Heron Therapeutics
HRTX
#7833
Rank
A$0.38 B
Marketcap
$2.53
Share price
3.27%
Change (1 day)
-3.97%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.87. In 2022 the company made an earnings per share (EPS) of -$2.77 an increase over its 2021 EPS that were of -$3.60.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-36.26%
2022-$2.77-23.11%
2021-$3.60-10%
2020-$4.00-0%
2019-$4.001.21%
2018-$3.95-32.7%
2017-$5.87-19.34%
2016-$7.2854.76%
2015-$4.701.73%
2014-$4.62-16.23%
2013-$5.5291.67%
2012-$2.88-31.45%
2011-$4.20-27.06%
2010-$5.76-43.75%
2009-$10.24-57.33%
2008-$24.00-82.92%
2007-$140.4620.61%
2006-$116.46175.76%
2005-$42.23-21.43%
2004-$53.75100%
2003-$26.88-38.24%
2002-$43.51161.54%
2001-$16.64-106.46%
2000$257.392051.55%
1999$11.96839.73%
1998$1.27-105.48%
1997-$23.25-88.16%
1996-$196.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.08-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.61 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.51-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.64 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA